Effect of dietary supplementation with Nigella sativa L. on serum lipid profile, lipid peroxidation and antioxidant defense system in hyperlipidemic rabbits

Journal of Medicinal Plants Research

Volumn 3, Issue 10, 2009, Pages 815-821

  Pourghassem Gargari, Bahram ^a   Ebrahimzadeh Attary, Vahideh ^a   Rafraf, Maryam ^a   Gorbani, Abolfazl ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Antioxidant status; Lipid profile; Malondialdehyde; Nigella sativa; Rabbits

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; GLUTATHIONE PEROXIDASE; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLACK CUMIN; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG ACTIVITY; EXPERIMENTAL RABBIT; HYPERLIPIDEMIA; HYPOLIPIDEMIC ACTIVITY; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; PLANT SEED; TRIACYLGLYCEROL BLOOD LEVEL;

NIGELLA SATIVA; ORYCTOLAGUS CUNICULUS;

EID: 73449115306     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Akhondian J, Parsa A, Rakhshande H (2007). The effect of Nigella sativa L. (black cumin seed) on intractable pediatric seizures. Med. Sci. Monit. 13: 555-9.
2. Akram KM (1999). Chemical composition and medicinal properties of Nigella sativa Linn. Inflammopharmacol. 7 (1): 15-35.
3. Ali BH, Blunden G (2003). Pharmacological and toxicological properties of Nigella sativa. Phytother. Res. 17 (4): 299-305.
4. Arts IC, Hollman PC (2005). Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 81: 317S-325S.
5. Badary OA, Abdel-Naim AB, Abdel-Wahab MH, Hamada FM (2000). The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats. Toxicol. 143 (3): 219-26.
6. Bamosa AO, Ali BA, al-Hawsawi ZA (2002). The effect of thymoquinone on blood lipids in rats. Indian. J. Physiol. Pharmacol. 46 (2): 195-201.
7. Brown L, Rosner B, Willett WW, Sacks FM (1999). Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am. J. Clin. Nutr. 69 (1): 30-42.
8. Burits M, Bucar F (2000). Antioxidant activity of Nigella sativa essential oil. Phytother. Res. 14 (5): 323-8.
9. Dehkordi FR, Kamkhah AF (2008). Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension. Fundam. Clin. Pharmacol. 22 (4): 447-52.
10. Del Rio D, Pellegrini N, Colombi B, Bianchi M, Serafini M, Torta F, et al (2003). Rapid fluorimetric method to detect total plasma malondialdehyde with mild derivatization conditions. Clin. Chem. 49(4): 690-2.
11. Djoussé L, Hunt SC, Arnett DK (2003). Dietary linoleic acid is inversely associated with plasma triacylglycerol: the National Heart, Lung, and Blood Institute Family Heart Study. Am. J. Clin. Nutr. 78(6): 1098-102
12. El-Beshbishy HA, Singab ANB, Sinkkonen J, Pihlaja K (2006). Hypolipidemic and antioxidant effects of Morus alba L. (Egyptian mulberry) root bark fractions supplementation in cholesterol-fed rats. Life Sci. 78: 2724-2733.
13. El-Dakhakhny M, Mady NI, Halim MA (2000). Nigella sativa L. oil protects against induced hepatotoxicity and improves serum lipid profile in rats. ARZNEIMITTEL. FORSCH. 50 (9): 832-6.
14. El-Din K, El-Tahir H, Bakeet DM (2006).The black seed (Nigella sativa Linnaeus)- a mine for multi cures: A plea for urgent clinical evaluation of its volatile oil. JTU. Med. Sci. 1: 1-19.
15. Friedewald WT, Levy RRI, Fredrickson DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of preparative ultracentrifuge. Clin. Chem. 18: 499 -502.
16. Gilani AH, Jabeen Q, Asad Ullah Khan M (2004). A review of medicinal uses and pharmacological activities of Nigella sativa. Pak. J. Biol. Sci. 7 (4): 441-451.
17. Hajhashemi V, Ghannadi A, Jafarabadi H (2004). Black cumin seed essential oil, as a potent analgesic and antiinflammatory drug. Phytother. Res. 18(3): 195-199.
18. Ibraheim ZZ (2002). Effect of Nigella sativa seeds and total oil on some blood parameters in female doxorubicin volunteers. Saudi Pharm. J. 10: 54-59.
19. Jaffar AR, Babb J, Movahed A (2004). Optimal management of hyperlipidemia in primary prevention of cardiovascular disease. Int. J. Cardiol. 97 (3): 355-366.
20. Jones PJ (1999). Cholesterol-lowering action of plant sterols. Curr. Atheroscler. Rep. 1 (3): 230-235.
21. Kaleem M, Kirmani D, Asif M, Ahmed Q, Bano B (2006). Biochemical effects of Nigella sativa L seeds in diabetic rats. Indian. J. Exp. Biol. 44 (9): 745-8.
22. Kalus U, Pruss A, Bystron J, Jurecka M, Smekalova A, Lichius JJ (2003). Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases. Phytother. Res. 17: 1209-14.
23. Kanter M, Coskun O, Budancamanak M (2005). Hepatoprotective effects of Nigella sativa L and Urtica dioica L on lipid peroxidation, antioxidant enzyme systems and liver enzymes in carbon tetrachloride-treated rats. World. J. Gastroenterol. 11 (42): 6684-8.
24. Kanter M, Coskun O, Kalayci M, Buyukbas S, Cagavi F (2006). Neuroprotective effects of Nigella sativa on experimental spinal cord injury in rats. Hum. Exp. Toxicol. 25 (3): 127-33.
25. Le PM, Benhaddou-Andaloussi A, Elimadi A, Settaf A, Cherrah Y, Haddad PS (2004). The petroleum ether extract of Nigella sativa exerts lipid-lowering and insulin-sensitizing actions in the rat. J. Ethnopharmacol. 94: 251-9.
26. Meral I, Yener Z, Kahraman T, Mert N (2001). Effect of Nigella sativa on glucose concentration, lipid peroxidation, antioxidant defence system and liver damage in experimentally induced diabetic rabbits. J. Vet. Med. Physiol. Pathol. Clin. Med. 48 (10): 593-9.
27. Moghadasian MH, Frohlich JJ, Scudamore CH (2002). Specificity of the commonly used enzymatic assay for plasma cholesterol determination. J. Clin. Pathol. 55 (11): 859-61.
28. Morikawa T, Xu F, Ninomiya K, Matsuda H, Yoshikawa M (2004). Nigellamines A3, A4, A5, and C, new dolabellane-type diterpene alkaloids, with lipid metabolism-promoting activities from the Egyptian medicinal food black cumin. Chem. Pharm. Bull. 52 (4): 494-7.
29. Moruisi KG, Oosthuizen W, Opperman AM (2006). Phytosterols/stanols lower cholesterol concentrations in familial hypercholesterolemic subjects: a systematic review with meta-analyses. J. Am. Coll. Nutr. 25 (1): 41-8.
30. Moyers SB, Kumar NB (2004). Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr. Rev. 62 (5): 204-211.
31. Padhye S, Banerjee S, Ahmad A, Mohammad R, Sarkar FH (2008). From here to eternity - the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond. Cancer. Ther. 6 (b): 495-510.
32. Prasad K (2005). Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed. Atherosclerosis. 179 (2): 269-275.
33. Ramadan MF (2007). Nutritional value, functional properties and nutraceutical applications of black cumin (Nigella sativa L.): an overview. Int. J. Food. Sci. Tech. 42 (10): 1208-1218.
34. Talati R, Baker WL, Pabilonia MS, White CM, Coleman CI (2009). The effects of barley-derived soluble fiber on serum lipids. Ann. Fam. Med. 7 (2): 157-163.
35. Uz E, Uz B, Selcoki Y, Bayrak R, Kaya A, Turgut HF (2008). Cardio-protective effects of Nigella sativa oil on cyclosporine A-induced cardiotoxicity in rats. Basic. Clin. Pharmacol. Toxicol. 103 (6): 574-80.
36. Weggemans RM, Trautwein EA (2003). Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a Meta analyses. Eur. J. Clin. Nutr. 57 (8): 940-946.
37. Zaoui A, Cherrah Y, Alaoui K, Mahassine N, Amarouch H, Hassar M (2002b). Effects of Nigella sativa fixed oil on blood homeostasis in rat. J. Ethnopharmacol. 79 (1): 23-6.
38. Zaoui A, Cherrah Y, Mahassini N, Alaoui K, Amarouch H, Hassar M (2002a). Acute and chronic toxicity of Nigella sativa fixed oil. Phytomedicine. 9(1): 69-74.